Uvavanyo lwe-Influenza A+B Antigen Rapid Test luvavanyiwe xa luthelekiswa ne-RT-PCR.I-539 ye-nasopharyngeal swabs kunye ne-oropharyngeal swabs zavandlakanywa kunye novavanyo olukhawulezayo lwe-Influenza A + B.
Izinto | Ukugxila | Izinto | Ukugxila |
Ukutshiza ngeempumlo | 15% v/v | IHemoglobin | 10% v/v |
Mucin | 0.5 % w/v | Mupirocin | 10 mg/mL |
Amathontsi ngeempumlo | 15% v/v | Ukuhlamba imilomo | / |
I-Chloraseptic | 1.5 mg/mL | Levofloxacin | 40 ug/mL |
I-Oseltamivir | 2ug/mL | I-Ribavirin | 0.2ug/mL |
I-Fluticasone propionate | 5% v/v | Ceftriaxone | 800 ug/mL |
Tobramycin | 4ug/mL | I-Saline yeeNcinci zokutshiza | 10% v/v |
NgoMkhuhlane A
Indlela | I-RT-PCR | Zizonke iziphumo | ||
Uvavanyo loMkhuhlane A+B oluKhawulezayo | Iziphumo | Okuhle | Ibi | |
Okuhle | 116 | 1 | 117 | |
Ibi | 5 | 417 | 422 | |
Zizonke iziphumo | 121 | 418 | 539 |
Uvakalelo lweklinikhi: 95.87% (95% CI: 90.69% ~ 98.22%)
Ubungcali beklinikhi: 99.76% (95% CI: 98.66% ~ 99.96%)
Ireyithi yeNxulumano iyonke: 98.89% (95% CI: 97.59% ~ 99.49%).
NgoMkhuhlane B:
Indlela | I-RT-PCR | Zizonke iziphumo | ||
Uvavanyo loMkhuhlane A+B oluKhawulezayo | Iziphumo | Okuhle | Ibi | |
Okuhle | 97 | 1 | 98 | |
Ibi | 6 | 435 | 441 | |
Zizonke iziphumo | 103 | 436 | 539 |
Uvakalelo lweklinikhi: 94.17% (95% CI: 87.87% ~ 97.30%)
Ubungcali beklinikhi: 99.77% (95% CI: 98.71% ~ 99.96%)
Ireyithi yeNxulumaniso iyonke: 98.70% (95% CI: 97.34% ~ 99.37%).
Uvakalelo lokuHlalutya/LOD
Hangzhou Aichek Medical Technology CO., Ltd. Jinxing Cun, Yuhang Community, Yuhang ISithili (IsiXeko seSayensi seNzululwazi yekamva), iHangzhou, Zhejiang, PR China | |
SUNGO Europe BV I-Olympisch Stadion 24, 1076DE Amsterdam, Netherlands |
Umda wokubhaqwa (LOD) ichongiwe ngokuvavanywa koxinzelelo olwahlukileyo lwentsholongwane yomkhuhlane A kunye nentsholongwane yomkhuhlane B kuMkhuhlane A+B we-Antigen Rapid Test.Ugxininiso oluchongwe njengamanqanaba eLOD avavanyiweyo zidweliswe ngezantsi.
Umkhuhlane A (H3N2): 5×103 TCID50/mL
Umkhuhlane A (H1N1): 2.5×103 TCID50/mL
Umkhuhlane A (H1N1 pdm09): 2.5×103 TCID50/mL
Umkhuhlane B (Yamagata): 3.5×103 TCID50/mL
I-Influenza B (i-Victoria): 1.0 × 103 TCID50 / mL
Ukuchaneka koHlahlo (Ukuphinda kusebenze kwakhona ngokunqamlezayo)
Ukumisela uhlalutyo oluthile lwe-Influenza A + B ye-Antigen Rapid Test, ii-microorganisms ezininzi ze-commensal okanye ze-pathogenic ezinokubakho kwindlela yokuphefumula ephezulu zavavanywa.
Iisampulu ezintle nezimbi zaye zajongwa ngezi ntsholongwane zavavanywa kuxinaniso lwe-106 TCID50/mL, kubandakanywa i-SARS-CoV-2, i-Human coronavirus HKU1, OC43, NL63, 229E, MERS, Rhinovirus, Adenovirus, Enterovirus, Metapneumotoryeumovirus, iParainflunza, iParainflunza syncytial virus, Mycoplasma pneumonia, Chlamydia pneumonia, Streptococcus pneumonia, Staphylococcus aureus, Mycobacterium tuberculosis, Haemophilus influenzae, Streptococcus pyogenes.Akukho kuphinda kusebenze kwakhona kubonwe ngoMkhuhlane A+B Antigen Rapid Test.
Umkhuhlane A+B Antigen Rapid Test is a lateral flow immunoassay eyenzelwe ukufunyaniswa komgangatho womkhuhlane A kunye neantigens zomkhuhlane B kwiswab ye-nasopharyngeal kunye ne-oropharyngeal swab.
1. UMvelisi oyiNgcali, ishishini “eliphambili” elikwinqanaba lesizwe
2.Hambisa iimpahla njengesicelo somyalelo
3.ISO13485, CE, Lungisa amaxwebhu ahlukeneyo okuthumela
4.Phendula imibuzo yabathengi kwiiyure ezingama-24